Filter
2021
Filtered Results: 2021
Text search:
cell
line
Featured
Recommendations
254
New Publications
569
Language
Document type
No document type
1203
Guidelines
329
Studies & Reports
249
Manuals
116
Strategic & Response Plan
41
Fact sheets
35
Training Material
23
Situation Updates
17
Brochures
3
Resource Platforms
3
Infographics
2
Countries / Regions
India
172
Global
64
South Africa
61
Kenya
59
Rwanda
44
Nepal
40
Tanzania
40
Nigeria
39
Uganda
39
Sierra Leone
37
Ethiopia
37
Africa
34
Zambia
29
Bangladesh
27
Liberia
27
Ghana
26
Malawi
25
Philippines
22
Western and Central Europe
20
Myanmar / Burma
19
Zimbabwe
18
Namibia
17
Asia
16
Latin America and the Carribbean
16
Congo, Democratic Republic of
15
Syria
13
Mozambique
13
Ukraine
12
Lesotho
10
Brazil
9
Indonesia
9
Senegal
8
Guinea
8
Venezuela
8
Germany
8
South–East Asia Region
8
West and Central Africa
7
Middle East and North Africa
7
Eastern Europe and Central Asia
7
USA
6
Haiti
6
Cambodia
6
Eastern Europe
6
Russia
6
Botswana
6
South Sudan
6
Eswatini/ Swaziland
6
Pakistan
6
Burkina Faso
5
Afghanistan
5
Papua New Guinea
5
Mali
5
Madagascar
5
Colombia
4
Thailand
4
Peru
4
Central African Republic
4
Somalia
4
Ecuador
4
Cameroon
3
East and Southern Africa
3
Lebanon
3
Vietnam
3
Sudan
3
Yemen
3
Iraq
3
North Macedonia
2
El Salvador
2
Turkey
2
Benin
2
China
2
Niger
2
Dominican Republic
2
Jordan
2
France
2
Spain
2
Belarus
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Bolivia
2
Argentina
2
Sri Lanka
2
Egypt
2
Greece
2
Georgia
2
Poland
2
Libya
2
Tajikistan
1
North Korea
1
Mexico
1
Gambia
1
Kazakhstan
1
Chile
1
Iran
1
Albania
1
Fiji
1
Laos
1
Estonia
1
Congo-Brazzaville
1
Vanuatu
1
Morocco
1
Mongolia
1
Qatar
1
Mauritania
1
Italy
1
Armenia
1
Guinea-Bissau
1
Hungary
1
Saudi Arabia
1
Western Pacific Region
1
North America
1
Tunisia
1
United Kingdom
1
Portugal
1
Israel
1
Latvia
1
Nicaragua
1
Moldova
1
Romania
1
Honduras
1
Chad
1
Bhutan
1
Solomon Islands
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
793
Clinical Guidelines
267
Public Health
112
Women & Child Health
110
Key Resources
56
Capacity Building
44
Pharmacy & Technologies
43
Toolboxes
HIV
232
COVID-19
173
TB
131
Rapid Response
69
NTDs
68
Ebola
62
Mental Health
57
NCDs
49
Planetary Health
48
Pharmacy
47
AMR
40
Conflict
38
Caregiver
35
Disability
28
Refugee
23
Natural Hazards
22
Zika
15
Polio
14
Global Health Education
14
Cholera
12
Specific Hazards
11
Social Ethics
9
Health Financing Toolbox
2
On 15–16 December 2020, WHO and the Medicines for Malaria Venture co-convened a technical consultation to consider the preferred product characteristics (PPCs) for drugs used in malaria chemoprevention. The main goal of the technical consultation was to agree on the most important PPCs for drugs t...
GDF is the largest global provider of quality-assured tuberculosis (TB)
medicines, diagnostics, and laboratory supplies to the public sector.
Since 2001, GDF has facilitated access to high-quality TB care in over 130
countries, providing treatments to over 30 million people with TB and procuring
...
Nat Commun 9, 5370 (2018). https://doi.org/10.1038/s41467-018-07804-8. Mycobacterium ulcerans is the causative agent of Buruli ulcer, a neglected tropical skin disease that is most commonly found in children from West and Central Africa. Despite the severity of the infection, therapeutic options are...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
Evidence-based guidelines are one of the most useful tools for improving public health and clinical practice. Their purpose is to formulate interventions based on strong evidence of efficacy, avoid unnecessary risks, use resources efficiently, reduce clinical variability and, in essence, improve hea...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
Antimicrobial resistance (AMR) is a threat to global health and development and it contributes to millions of deaths worldwide each year. Inappropriate use and overuse of antibiotics are driving an increase in AMR and have a detrimental impact on the effectiveness of these critical medicines. Throug...
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Discrete typing units of Trypanosoma cruzi: Geographical and biological distribution in the Americas
Chagas disease caused by Trypanosoma cruzi is a public health issue in Latin America. This highly diverse parasite is divided into at least seven discrete typing units (DTUs) TcI-TcVI and Tcbat. Some DTUs have been associated with geographical distribution in epidemiological scenarios and clinical m...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa...
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. If not diagnosed at early stages, patients with CBM...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
Rabies is a fatal viral zoonosis and serious public health problem.1 All mammals are believed to be susceptible to the disease, and for the purposes of this document, use of the term animal refers to mammals. The disease is an acute, progressive encephalitis caused by viruses in the genus Lyssavirus...
Since 24 February 2022, the war in Ukraine has caused widespread suffering to its people and serious damage
to the country’s infrastructure. Attacks on the country’s health system and its power network threaten people, compromise the provision of health care, and complicate the distribution of ...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
